Lihong Xu

ORCID: 0000-0002-9334-1271 · 2 papers in corpus · active 2021

Study types

  • article 1
  • preprint 1

Condition tags

  • adenomyosis 2
preprint 2021
·doi:10.21203/rs.3.rs-506178/v1

Abstract Gonadotropin-releasing hormone agonist(GnRH-a) is generally added to improve pregnancy outcomes of adenomyosis based hormone replacement therapy cycle. Our objective in this study is to investigate whether adding GnRH-a can obtain …

article 2021
Scientific reports ·doi:10.1038/s41598-021-98918-5

Gonadotropin-releasing hormone agonist (GnRH-a) is generally added to the improve pregnancy outcomes of hormone replacement therapy cycles among patients with adenomyosis. We aimed to investigate whether adding GnRH-a can result in better p…